To The Moon

Log In/Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 111,888 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 3.79% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Veracyte by 50,616 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 4.61% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 1,036 shares, the number of shares held decreased 4.1% compared to the previous period and now represents 0.98% of the total position.
      51Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Veeva by 2,701 shares, the number of shares held decreased 4.11% compared to the previous period and now represents 1.3% of the total position.
      3Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 89,170 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 9.53% of the total position.
      70Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 477,115 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 7% of the total position.
      16Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Tempus AI by 27,572 shares, the number of shares held decreased 2.06% compared to the previous period and now represents 4.41% of the total position.
      129Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 90,021 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 3.84% of the total position.
      34Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 509,231 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 1.88% of the total position.
      16Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:11
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 121,064 shares, the number of shares held decreased 4.08% compared to the previous period and now represents 2.58% of the total position.
      3Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed

       
       
       
       
       

      Terms and Conditions·Privacy Policy

      Company: TTMF Limited. Tech supported by Xiangshang Yixin.

      Email：uservice@ttm.financial